GlassScriptPhysician profile
Christopher K Wong
NPI 1275508392
$819.32
in general payments reported to CMS, 2019-2025
14 companies · $380 in 2025
The $380 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.19 · 2021: $11.56 · 2022: $14.45 · 2023: $122 · 2024: $263 · 2025: $380.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $149.62 | 2025 | Tremfya |
| Exact Sciences Corporation | $135.34 | 2023-2024 | Cologuard Collection Kit |
| Abiomed | $129.71 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.09 | 2024 | Spevigo |
| Pfizer INC. | $67.38 | 2024-2025 | |
| Zoll Circulation INC | $36.16 | 2025 | Therox Ds2 Console, Downstream Cartridge, Catheter |
| Biosense Webster, INC. | $33.61 | 2024 | Nuvision Ice Catheter |
| Abbott Laboratories | $29.49 | 2025 | Amplatzer |
| Janssen Scientific Affairs, LLC | $27.53 | 2024 | Xarelto |
| Boston Scientific Corporation | $27.19 | 2019 | |
| Impulse Dynamics (USA) INC. | $23.50 | 2023 | Optimizer |
| Lantheus Medical Imaging, INC. | $22.69 | 2023 | Definity |
| Novo Nordisk INC | $14.45 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.